Colon-targeted drug delivery enables site-specific therapy for colonic disorders with reduced systemic effects. This review highlights conventional and advanced strategies, including stimulus-responsive, polysaccharide-based, and nanocarrier systems.
Mishra et al. (Thu,) studied this question.